{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T07:37:47Z","timestamp":1773387467276,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,7,17]],"date-time":"2011-07-17T00:00:00Z","timestamp":1310860800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s10792-011-9455-7","type":"journal-article","created":{"date-parts":[[2011,7,16]],"date-time":"2011-07-16T12:34:37Z","timestamp":1310819677000},"page":"341-344","source":"Crossref","is-referenced-by-count":6,"title":["Intravitreal voriconazole for the treatment of Aspergillus chorioretinitis"],"prefix":"10.1007","volume":"31","author":[{"given":"Jorge","family":"Vila Arteaga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayerling Mercedes","family":"Suriano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oana","family":"Stirbu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,7,17]]},"reference":[{"key":"9455_CR1","unstructured":"Moorthy R, Davis J, Yen Lowder C et al (2009) Inflamaci\u00f3n intraocular y uveitis. In: Liesegang T, Skuta G, Cantor L (eds) Curso de Ciencias B\u00e1sicas y Cl\u00ednicas. Elsevier Science, Spain, pp 250\u2013251"},{"key":"9455_CR2","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/01.iae.0000250011.68532.a2","volume":"26","author":"P Sen","year":"2006","unstructured":"Sen P, Gopal L, Ranjan P (2006) Intravitreal voriconazole for drug-resistant fungal endophthalmitis. Retina 26:935\u2013939","journal-title":"Retina"},{"key":"9455_CR3","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/j.1469-0691.2010.03334.x","volume":"16","author":"A Groll","year":"2010","unstructured":"Groll A, Tragiannidis A (2010) Update on antifungal agents for paediatric patients. Clin Microbiol Infect 16:1343\u20131353. doi: 10.1111\/j.1469-0691.2010.03334.x","journal-title":"Clin Microbiol Infect"},{"key":"9455_CR4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1586\/14787210.2.4.485","volume":"2","author":"R Herbrecht","year":"2004","unstructured":"Herbrecht R (2004) Voriconazole: therapeutic review of a new azole antifungal. Expert Rev Anti-infect Ther 2:485\u2013497","journal-title":"Expert Rev Anti-infect Ther"},{"key":"9455_CR5","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","volume":"347","author":"R Herbrecht","year":"2002","unstructured":"Herbrecht R, Denning DW, Patterson TF et al (2002) Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347:408\u2013415","journal-title":"N Engl J Med"},{"key":"9455_CR6","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1128\/AAC.46.4.1032-1037.2002","volume":"46","author":"MA Pfaller","year":"2002","unstructured":"Pfaller MA (2002) Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000. Antimicrob Agents Chemother 46:1032\u20131037","journal-title":"Antimicrob Agents Chemother"},{"key":"9455_CR7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/archopht.122.1.42","volume":"122","author":"SM Hariprasad","year":"2004","unstructured":"Hariprasad SM, Mieler WF, Holz ER et al (2004) Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans. Arch Ophthalmol 122:42\u201347","journal-title":"Arch Ophthalmol"},{"key":"9455_CR8","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.ophtha.2006.01.059","volume":"113","author":"M Kramer","year":"2006","unstructured":"Kramer M, Kramer MR, Blau H et al (2006) Intravitreal voriconazole for the treatment of endogenous Aspergillus endophthalmitis. Ophthalmology 113:1184\u20131186","journal-title":"Ophthalmology"},{"key":"9455_CR9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/jop.2007.0105","volume":"24","author":"RC Lin","year":"2008","unstructured":"Lin RC, Sanduja N, Hariprasad SM (2008) Successful treatment of postoperative fungal endophthalmitis using intravitreal and intracameral voriconazole. J Ocul Pharmacol Ther 24:245\u2013248","journal-title":"J Ocul Pharmacol Ther"},{"key":"9455_CR10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1128\/AAC.00762-06","volume":"51","author":"M Thiel","year":"2007","unstructured":"Thiel M, Zinkernagel AS, Burhenne J et al (2007) Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis. Antimicrob Agents Chemother 51:239\u2013244","journal-title":"Antimicrob Agents Chemother"},{"key":"9455_CR11","first-page":"183","volume":"101","author":"G Hua","year":"2003","unstructured":"Hua G, Pennesi M, Shah K et al (2003) Safety of intravitreal voriconazole: electroretinographic and histopathologic studies. Trans Am Ophthalmol Soc 101:183\u2013189","journal-title":"Trans Am Ophthalmol Soc"},{"key":"9455_CR12","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ajo.2003.08.037","volume":"137","author":"IU Scott","year":"2004","unstructured":"Scott IU, Cruz-Villegas V, Flynn HW et al (2004) Delayed onset, bleb-associated endophthalmitis caused by Lecythophora mutabilis. Am J Ophthalmol 137:583\u2013585","journal-title":"Am J Ophthalmol"},{"key":"9455_CR13","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1055\/s-2001-15911","volume":"218","author":"M Bagnoud","year":"2001","unstructured":"Bagnoud M, Baglivo E, Hengstlerl J et al (2001) Endogenous fungal endophthalmitis: results of antifungal treatment with and without vitrectomy. Klin Monbl Augenheilkd 218:398\u2013400","journal-title":"Klin Monbl Augenheilkd"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-011-9455-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-011-9455-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-011-9455-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T00:30:23Z","timestamp":1559262623000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-011-9455-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,17]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["9455"],"URL":"https:\/\/doi.org\/10.1007\/s10792-011-9455-7","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,17]]}}}